Literature DB >> 15614506

In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.

Raphaël Boisgard1, Bertrand Kuhnast, Stefan Vonhoff, Chéraz Younes, Françoise Hinnen, Jean-Marc Verbavatz, Bernard Rousseau, Jens Peter Fürste, Britta Wlotzka, Frédéric Dollé, Sven Klussmann, Bertrand Tavitian.   

Abstract

PURPOSE: Single-stranded mirror-image oligonucleotides (Spiegelmers) are highly resistant to nuclease degradation and are capable of tightly and specifically binding to protein targets. Here we explored the potential of Spiegelmers as in vivo imaging probes for positron emission tomography (PET).
METHODS: We investigated the biodistribution and pharmacokinetics of [18F]-L-DNA and [18F]-L-RNA Spiegelmers by dynamic quantitative whole-body PET imaging after intravenous administration in non-human primates. Their metabolic profile was explored in primates and rats, and ex vivo autoradiography of [(125)I]-L-RNA was performed in rat kidneys, the major organ for Spiegelmer uptake.
RESULTS: Both [18F]-L-DNA and [18F]-L-RNA Spiegelmers were metabolically stable in plasma during 2 h after injection. No evidence of non-specific binding was found with either type of Spiegelmer in any tissue.
CONCLUSION: The biodistribution and metabolic profiles of [18F]-L-DNA and [18F]-L-RNA Spiegelmers highlight their potential as radiotracers for in vivo imaging applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15614506     DOI: 10.1007/s00259-004-1669-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  32 in total

1.  In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography.

Authors:  E O. Aboagye; P M. Price; T Jones
Journal:  Drug Discov Today       Date:  2001-03-01       Impact factor: 7.851

2.  Escort aptamers: a delivery service for diagnosis and therapy.

Authors:  B J Hicke; A W Stephens
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen.

Authors:  M Blank; T Weinschenk; M Priemer; H Schluesener
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

4.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

5.  A DNA Spiegelmer to staphylococcal enterotoxin B.

Authors:  Werner G Purschke; Falko Radtke; Frank Kleinjung; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

Review 6.  Pharmacokinetic considerations in the development of oligomers as radiopharmaceuticals.

Authors:  D J Hnatowich
Journal:  Q J Nucl Med       Date:  1997-06

7.  Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.

Authors:  Dirk Faulhammer; Bernd Eschgfäller; Sandra Stark; Petra Burgstaller; Werner Englberger; Jeannette Erfurth; Frank Kleinjung; Johanna Rupp; Sebastian Dan Vulcu; Werner Schröder; Stefan Vonhoff; Hermann Nawrath; Clemens Gillen; Sven Klussmann
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

8.  Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.

Authors:  S Agrawal; J Temsamani; J Y Tang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class.

Authors:  Britta Wlotzka; Susanne Leva; Bernd Eschgfäller; Jens Burmeister; Frank Kleinjung; Christine Kaduk; Peter Muhn; Holger Hess-Stumpp; Sven Klussmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

Review 10.  Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives.

Authors:  Cheraz Khélifi Younes; Raphaël Boisgard; Bertrand Tavitian
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

View more
  4 in total

1.  A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis.

Authors:  Kai Hoehlig; Christian Maasch; Nelli Shushakova; Klaus Buchner; Markus Huber-Lang; Werner G Purschke; Axel Vater; Sven Klussmann
Journal:  Mol Ther       Date:  2013-07-26       Impact factor: 11.454

Review 2.  Mirror-Image Oligonucleotides: History and Emerging Applications.

Authors:  Brian E Young; Nandini Kundu; Jonathan T Sczepanski
Journal:  Chemistry       Date:  2019-04-26       Impact factor: 5.236

Review 3.  Merging molecular imaging and RNA interference: early experience in live animals.

Authors:  Alexei A Bogdanov
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

Review 4.  Chemical architecture and applications of nucleic acid derivatives containing 1,2,3-triazole functionalities synthesized via click chemistry.

Authors:  Tim Efthymiou; Wei Gong; Jean-Paul Desaulniers
Journal:  Molecules       Date:  2012-10-26       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.